Cargando…
Reduced and optimized trial designs for drugs described by a target mediated drug disposition model
Monoclonal antibodies against soluble targets are often rich and include the sampling of multiple analytes over a lengthy period of time. Predictive models built on data obtained in such studies can be useful in all drug development phases. If adequate model predictions can be maintained with a redu...
Autores principales: | Brekkan, A., Jönsson, S., Karlsson, M. O., Hooker, A. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061097/ https://www.ncbi.nlm.nih.gov/pubmed/29948794 http://dx.doi.org/10.1007/s10928-018-9594-9 |
Ejemplares similares
-
Dynamics of target-mediated drug disposition: characteristic profiles and parameter identification
por: Peletier, Lambertus A., et al.
Publicado: (2012) -
Handling underlying discrete variables with bivariate mixed hidden Markov models in NONMEM
por: Brekkan, A., et al.
Publicado: (2019) -
Target‐Mediated Drug Disposition Model for Bispecific Antibodies: Properties, Approximation, and Optimal Dosing Strategy
por: Schropp, Johannes, et al.
Publicado: (2019) -
A Tutorial on Target-Mediated Drug Disposition (TMDD) Models
por: Dua, P, et al.
Publicado: (2015) -
Target Mediated Drug Disposition Model of CPHPC in Patients with Systemic Amyloidosis
por: Sahota, T, et al.
Publicado: (2015)